Your browser doesn't support javascript.
loading
Autoantibody Development under Treatment with Immune-Checkpoint Inhibitors.
de Moel, Emma C; Rozeman, Elisa A; Kapiteijn, Ellen H; Verdegaal, Els M E; Grummels, Annette; Bakker, Jaap A; Huizinga, Tom W J; Haanen, John B; Toes, René E M; van der Woude, Diane.
Afiliação
  • de Moel EC; Department of Rheumatology, Leiden University Medical Center, Leiden, the Netherlands. e.c.de_moel@lumc.nl.
  • Rozeman EA; Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Kapiteijn EH; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands.
  • Verdegaal EME; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands.
  • Grummels A; Department of Clinical Chemistry and Laboratory Medicine, Leiden University Medical Center, Leiden, the Netherlands.
  • Bakker JA; Department of Clinical Chemistry and Laboratory Medicine, Leiden University Medical Center, Leiden, the Netherlands.
  • Huizinga TWJ; Department of Rheumatology, Leiden University Medical Center, Leiden, the Netherlands.
  • Haanen JB; Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Toes REM; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands.
  • van der Woude D; Department of Rheumatology, Leiden University Medical Center, Leiden, the Netherlands.
Cancer Immunol Res ; 7(1): 6-11, 2019 01.
Article em En | MEDLINE | ID: mdl-30425107

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Autoanticorpos / Ipilimumab / Antineoplásicos Imunológicos / Melanoma Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Autoanticorpos / Ipilimumab / Antineoplásicos Imunológicos / Melanoma Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article